NCT01303614

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice: a Prospective Randomized Double Blind, Placebo-controlled Clinical Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Consorci Sanitari de Terrassa · Academic / Other
• Sex: Female
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysterosalpingography diagnostic practice.

Conditions

• Gynecological Pathology

Interventions

Type	Name	Description
DRUG	Lidocaine-Prilocaine cream	Implementation of 3 cm of lidocaine-prilocaine in the endocervical canal, 10 minutes before the intervention with a syringe without needle 5ml. Application, with a swab of the anesthetic cream ectocervix level.
DRUG	placebo	3 cm of gel application for the transmission of ultrasound into the endocervical canal 10 minutes before surgery, with a 5 ml syringe without needle. Application, with a swab in gel ectocervix.

Timeline

• Start date: 2011-04-01
• Primary completion: 2012-04-01
• Completion: 2012-09-01
• First posted: 2011-02-25
• Last updated: 2011-02-25

Locations

1 site across 1 country: Spain